Industry Research Reports

Home > Reports > Pharma & Healthcare > Enasidenib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Enasidenib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Pharma & Healthcare

Published Date: 2026-07-14

Pages: 125 Pages

Report ld: 6939333

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Enasidenib Market Size(US$)

CAGR 2026-2032

7.1%

Market Size,2032

USD 152

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 100 million

Market Forecast in 2032(Value)

US$ 152 million

CAGR

7.1%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Enasidenib was estimated to be worth US$ 94.4 million in 2025 and is projected to reach US$ 152 million, growing at a CAGR of 7.1% from 2026 to 2032.

Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test

Enasidenib is a targeted therapy used to treat relapsed or refractory acute myeloid leukemia (AML) with an IDH2 mutation. Its efficacy in inhibiting the mutated IDH2 enzyme and inducing remission has driven market growth. The limited treatment options for this specific subset of AML contribute to its niche status. However, challenges include potential side effects and the need for genetic testing to identify eligible patients. The market competition is relatively small, as Enasidenib remains a targeted therapy for a specific AML subgroup. Despite challenges, the Enasidenib market offers potential for growth as healthcare providers seek effective treatments for patients with IDH2-mutated AML. Continued research and clinical advancements can further drive market expansion.

This report provides a comprehensive view of the global market for Enasidenib, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Enasidenib market size, estimations, and forecasts are presented in terms of sales volume (Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Enasidenib.

MARKET SEGMENTATION

By Company

Bristol Myers Squibb

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

50mg
100mg

Segment by Application

Hospital
Pharmacy

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.

Chapter 2: Provides a detailed analysis of the Enasidenib manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Enasidenib sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Enasidenib sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.

Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Enasidenib Product Introduction

1.2 Global Enasidenib Market Size Forecast

1.2.1 Global Enasidenib Sales Value (2021–2032)

1.2.2 Global Enasidenib Sales Volume (2021–2032)

1.2.3 Global Enasidenib Sales Price (2021–2032)

1.3 Enasidenib Market Trends & Drivers

1.3.1 Enasidenib Industry Trends

1.3.2 Enasidenib Market Drivers & Opportunities

1.3.3 Enasidenib Market Challenges

1.3.4 Enasidenib Market Restraints

1.3.5 Impact of U.S. Tariffs

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Enasidenib Players Revenue Ranking (2025)

2.2 Global Enasidenib Revenue by Company (2021–2026)

2.3 Global Enasidenib Sales Volume Ranking of Players (2025)

2.4 Global Enasidenib Sales Volume by Company (2021–2026)

2.5 Global Enasidenib Average Price by Company (2021–2026)

2.6 Key Manufacturers Enasidenib Manufacturing Base and Headquarters

2.7 Key Manufacturers Enasidenib Product Offerings

2.8 Key Manufacturers Start of Mass Production of Enasidenib

2.9 Enasidenib Market Competitive Analysis

2.9.1 Enasidenib Market Concentration Rate (2021–2026)

2.9.2 Global 5 and 10 Largest Manufacturers by Enasidenib Revenue in 2025

2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Enasidenib revenue, 2025

2.10 Mergers & Acquisitions and Expansion

3 Segmentation Enasidenib Market Classification

3.1 Introduction by Type

3.1.1 50mg

3.1.2 100mg

3.1.3 Global Enasidenib Sales Value by Type

3.1.3.1 Global Enasidenib Sales Value by Type (2021 vs 2025 vs 2032)

3.1.3.2 Global Enasidenib Sales Value, by Type (2021–2032)

3.1.3.3 Global Enasidenib Sales Value, by Type (%), 2021–2032

3.1.4 Global Enasidenib Sales Volume by Type

3.1.4.1 Global Enasidenib Sales Volume by Type (2021 vs 2025 vs 2032)

3.1.4.2 Global Enasidenib Sales Volume, by Type (2021–2032)

3.1.4.3 Global Enasidenib Sales Volume, by Type (%), 2021–2032

3.1.5 Global Enasidenib Average Price by Type (2021–2032)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Pharmacy

4.2 Global Enasidenib Sales Value by Application

4.2.1 Global Enasidenib Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Enasidenib Sales Value, by Application (2021–2032)

4.2.3 Global Enasidenib Sales Value, by Application (%), 2021–2032

4.3 Global Enasidenib Sales Volume by Application

4.3.1 Global Enasidenib Sales Volume by Application (2021 vs 2025 vs 2032)

4.3.2 Global Enasidenib Sales Volume, by Application (2021–2032)

4.3.3 Global Enasidenib Sales Volume, by Application (%), 2021–2032

4.4 Global Enasidenib Average Price by Application (2021–2032)

5 Segmentation by Region

5.1 Global Enasidenib Sales Value by Region

5.1.1 Global Enasidenib Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Enasidenib Sales Value by Region (2021–2026)

5.1.3 Global Enasidenib Sales Value by Region (2027–2032)

5.1.4 Global Enasidenib Sales Value by Region (%), 2021–2032

5.2 Global Enasidenib Sales Volume by Region

5.2.1 Global Enasidenib Sales Volume by Region: 2021 vs 2025 vs 2032

5.2.2 Global Enasidenib Sales Volume by Region (2021–2026)

5.2.3 Global Enasidenib Sales Volume by Region (2027–2032)

5.2.4 Global Enasidenib Sales Volume by Region (%), 2021–2032

5.3 Global Enasidenib Average Price by Region (2021–2032)

5.4 North America

5.4.1 North America Enasidenib Sales Value, 2021–2032

5.4.2 North America Enasidenib Sales Value by Country (%), 2025 vs 2032

5.5 Europe

5.5.1 Europe Enasidenib Sales Value, 2021–2032

5.5.2 Europe Enasidenib Sales Value by Country (%), 2025 vs 2032

5.6 Asia Pacific

5.6.1 Asia Pacific Enasidenib Sales Value, 2021–2032

5.6.2 Asia Pacific Enasidenib Sales Value by Region (%), 2025 vs 2032

5.7 South America

5.7.1 South America Enasidenib Sales Value, 2021–2032

5.7.2 South America Enasidenib Sales Value by Country (%), 2025 vs 2032

5.8 Middle East & Africa

5.8.1 Middle East & Africa Enasidenib Sales Value, 2021–2032

5.8.2 Middle East & Africa Enasidenib Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Enasidenib Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Enasidenib Sales Value and Sales Volume

6.2.1 Key Countries/Regions Enasidenib Sales Value, 2021–2032

6.2.2 Key Countries/Regions Enasidenib Sales Volume, 2021–2032

6.3 United States

6.3.1 United States Enasidenib Sales Value, 2021–2032

6.3.2 United States Enasidenib Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Enasidenib Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Enasidenib Sales Value, 2021–2032

6.4.2 Europe Enasidenib Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Enasidenib Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Enasidenib Sales Value, 2021–2032

6.5.2 China Enasidenib Sales Value by Type (%), 2025 vs 2032

6.5.3 China Enasidenib Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Enasidenib Sales Value, 2021–2032

6.6.2 Japan Enasidenib Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Enasidenib Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Enasidenib Sales Value, 2021–2032

6.7.2 South Korea Enasidenib Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Enasidenib Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Enasidenib Sales Value, 2021–2032

6.8.2 Southeast Asia Enasidenib Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Enasidenib Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Enasidenib Sales Value, 2021–2032

6.9.2 India Enasidenib Sales Value by Type (%), 2025 vs 2032

6.9.3 India Enasidenib Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Bristol Myers Squibb

7.1.1 Bristol Myers Squibb Company Information

7.1.2 Bristol Myers Squibb Introduction and Business Overview

7.1.3 Bristol Myers Squibb Enasidenib Sales, Revenue, Price and Gross Margin (2021–2026)

7.1.4 Bristol Myers Squibb Enasidenib Product Offerings

7.1.5 Bristol Myers Squibb Recent Developments

8 Industry Chain Analysis

8.1 Enasidenib Industrial Chain

8.2 Enasidenib Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customer Analysis)

8.5 Sales Model and Sales Channelss

8.5.1 Enasidenib Sales Model

8.5.2 Sales Channels

8.5.3 Enasidenib Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Enasidenib Market Trends

Table 2. Enasidenib Market Drivers & Opportunities

Table 3. Enasidenib Market Challenges

Table 4. Enasidenib Market Restraints

Table 5. Global Enasidenib Revenue by Company (US$ Million), 2021–2026

Table 6. Global Enasidenib Revenue Market Share by Company (2021–2026)

Table 7. Global Enasidenib Sales Volume by Company (Units), 2021–2026

Table 8. Global Enasidenib Sales Volume Market Share by Company (2021–2026)

Table 9. Global Market Enasidenib Price by Company (USD/Unit), 2021–2026

Table 10. Key Manufacturers Enasidenib Manufacturing Base and Headquarters

Table 11. Key Manufacturers Enasidenib Product Type

Table 12. Key Manufacturers Start of Mass Production of Enasidenib

Table 13. Global Enasidenib Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Enasidenib revenue, 2025

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Enasidenib Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Enasidenib Sales Value by Type (US$ Million), 2021–2026

Table 18. Global Enasidenib Sales Value by Type (US$ Million), 2027–2032

Table 19. Global Enasidenib Sales Market Share in Value by Type (2021–2026)

Table 20. Global Enasidenib Sales Market Share in Value by Type (2027–2032)

Table 21. Global Enasidenib Sales Volume by Type: 2021 vs 2025 vs 2032 (Units)

Table 22. Global Enasidenib Sales Volume by Type (Units), 2021–2026

Table 23. Global Enasidenib Sales Volume by Type (Units), 2027–2032

Table 24. Global Enasidenib Sales Market Share in Volume by Type (2021–2026)

Table 25. Global Enasidenib Sales Market Share in Volume by Type (2027–2032)

Table 26. Global Enasidenib Price by Type (USD/Unit), 2021–2026

Table 27. Global Enasidenib Price by Type (USD/Unit), 2027–2032

Table 28. Global Enasidenib Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 29. Global Enasidenib Sales Value by Application (US$ Million), 2021–2026

Table 30. Global Enasidenib Sales Value by Application (US$ Million), 2027–2032

Table 31. Global Enasidenib Sales Market Share in Value by Application (2021–2026)

Table 32. Global Enasidenib Sales Market Share in Value by Application (2027–2032)

Table 33. Global Enasidenib Sales Volume by Application: 2021 vs 2025 vs 2032 (Units)

Table 34. Global Enasidenib Sales Volume by Application (Units), 2021–2026

Table 35. Global Enasidenib Sales Volume by Application (Units), 2027–2032

Table 36. Global Enasidenib Sales Market Share in Volume by Application (2021–2026)

Table 37. Global Enasidenib Sales Market Share in Volume by Application (2027–2032)

Table 38. Global Enasidenib Price by Application (USD/Unit), 2021–2026

Table 39. Global Enasidenib Price by Application (USD/Unit), 2027–2032

Table 40. Global Enasidenib Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 41. Global Enasidenib Sales Value by Region (US$ Million), 2021–2026

Table 42. Global Enasidenib Sales Value by Region (US$ Million), 2027–2032

Table 43. Global Enasidenib Sales Value by Region (%), 2021–2026

Table 44. Global Enasidenib Sales Value by Region (%), 2027–2032

Table 45. Global Enasidenib Sales Volume by Region (Units): 2021 vs 2025 vs 2032

Table 46. Global Enasidenib Sales Volume by Region (Units), 2021–2026

Table 47. Global Enasidenib Sales Volume by Region (Units), 2027–2032

Table 48. Global Enasidenib Sales Volume by Region (%), 2021–2026

Table 49. Global Enasidenib Sales Volume by Region (%), 2027–2032

Table 50. Global Enasidenib Average Price by Region (USD/Unit), 2021–2026

Table 51. Global Enasidenib Average Price by Region (USD/Unit), 2027–2032

Table 52. Key Countries/Regions Enasidenib Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 53. Key Countries/Regions Enasidenib Sales Value, (US$ Million), 2021–2026

Table 54. Key Countries/Regions Enasidenib Sales Value, (US$ Million), 2027–2032

Table 55. Key Countries/Regions Enasidenib Sales Volume, (Units), 2021–2026

Table 56. Key Countries/Regions Enasidenib Sales Volume, (Units), 2027–2032

Table 57. Bristol Myers Squibb Company Information

Table 58. Bristol Myers Squibb Introduction and Business Overview

Table 59. Bristol Myers Squibb Enasidenib Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021–2026)

Table 60. Bristol Myers Squibb Enasidenib Product Offerings

Table 61. Bristol Myers Squibb Recent Developments

Table 62. Key Raw Materials Lists

Table 63. Key Suppliers of Raw Materials Lists

Table 64. Enasidenib Downstream Customers

Table 65. Enasidenib Distributors List

Table 66. Research Programs/Design for This Report

Table 67. Key Data Information from Secondary Sources

Table 68. Key Data Information from Primary Sources

List of Figures

Figure 1. Enasidenib Product Picture

Figure 2. Global Enasidenib Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Enasidenib Sales Value (US$ Million), 2021–2032

Figure 4. Global Enasidenib Sales Volume (Units), 2021–2032

Figure 5. Global Enasidenib Sales Price (USD/Unit), 2021–2032

Figure 6. Enasidenib Report Years Considered

Figure 7. Global Enasidenib Players Revenue Ranking (US$ Million), 2025

Figure 8. Global Enasidenib Sales Volume Ranking of Players (Units), 2025

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Enasidenib Revenue in 2025

Figure 10. Enasidenib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 11. 50mg Picture

Figure 12. 100mg Picture

Figure 13. Global Enasidenib Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Enasidenib Sales Value Market Share by Type, 2025 & 2032

Figure 15. Global Enasidenib Sales Volume by Type (Units), 2021 vs 2025 vs 2032

Figure 16. Global Enasidenib Sales Volume Market Share by Type, 2025 & 2032

Figure 17. Global Enasidenib Price by Type (USD/Unit), 2021–2032

Figure 18. Product Picture of Hospital

Figure 19. Product Picture of Pharmacy

Figure 20. Global Enasidenib Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 21. Global Enasidenib Sales Value Market Share by Application, 2025 & 2032

Figure 22. Global Enasidenib Sales Volume by Application (Units), 2021 vs 2025 vs 2032

Figure 23. Global Enasidenib Sales Volume Market Share by Application, 2025 & 2032

Figure 24. Global Enasidenib Price by Application (USD/Unit), 2021–2032

Figure 25. North America Enasidenib Sales Value (US$ Million), 2021–2032

Figure 26. North America Enasidenib Sales Value by Country (%), 2025 vs 2032

Figure 27. Europe Enasidenib Sales Value (US$ Million), 2021–2032

Figure 28. Europe Enasidenib Sales Value by Country (%), 2025 vs 2032

Figure 29. Asia Pacific Enasidenib Sales Value (US$ Million), 2021–2032

Figure 30. Asia Pacific Enasidenib Sales Value by Region (%), 2025 vs 2032

Figure 31. South America Enasidenib Sales Value (US$ Million), 2021–2032

Figure 32. South America Enasidenib Sales Value by Country (%), 2025 vs 2032

Figure 33. Middle East & Africa Enasidenib Sales Value (US$ Million), 2021–2032

Figure 34. Middle East & Africa Enasidenib Sales Value by Country (%), 2025 vs 2032

Figure 35. Key Countries/Regions Enasidenib Sales Value (%), 2021–2032

Figure 36. Key Countries/Regions Enasidenib Sales Volume (%), 2021–2032

Figure 37. United States Enasidenib Sales Value (US$ Million), 2021–2032

Figure 38. United States Enasidenib Sales Value by Type (%), 2025 vs 2032

Figure 39. United States Enasidenib Sales Value by Application (%), 2025 vs 2032

Figure 40. Europe Enasidenib Sales Value (US$ Million), 2021–2032

Figure 41. Europe Enasidenib Sales Value by Type (%), 2025 vs 2032

Figure 42. Europe Enasidenib Sales Value by Application (%), 2025 vs 2032

Figure 43. China Enasidenib Sales Value (US$ Million), 2021–2032

Figure 44. China Enasidenib Sales Value by Type (%), 2025 vs 2032

Figure 45. China Enasidenib Sales Value by Application (%), 2025 vs 2032

Figure 46. Japan Enasidenib Sales Value (US$ Million), 2021–2032

Figure 47. Japan Enasidenib Sales Value by Type (%), 2025 vs 2032

Figure 48. Japan Enasidenib Sales Value by Application (%), 2025 vs 2032

Figure 49. South Korea Enasidenib Sales Value (US$ Million), 2021–2032

Figure 50. South Korea Enasidenib Sales Value by Type (%), 2025 vs 2032

Figure 51. South Korea Enasidenib Sales Value by Application (%), 2025 vs 2032

Figure 52. Southeast Asia Enasidenib Sales Value (US$ Million), 2021–2032

Figure 53. Southeast Asia Enasidenib Sales Value by Type (%), 2025 vs 2032

Figure 54. Southeast Asia Enasidenib Sales Value by Application (%), 2025 vs 2032

Figure 55. India Enasidenib Sales Value (US$ Million), 2021–2032

Figure 56. India Enasidenib Sales Value by Type (%), 2025 vs 2032

Figure 57. India Enasidenib Sales Value by Application (%), 2025 vs 2032

Figure 58. Enasidenib Industrial Chain

Figure 59. Enasidenib Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Enasidenib in 2026? zhanKai

The global market size of Enasidenib in 2026 was 100 Million USD.

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Enasidenib market? shouQi

What was the global market size of Enasidenib in 2032? shouQi

What is the annual compound growth rate of the global Enasidenib market size from 2026 to 2032? shouQi

Related Reports

Global Enasidenib Market Research Report 2026
The global Enasidenib market was valued at US$ 94.4 million in 2025 and is anticipated to reach US$ 152 million by 2032, at a CAGR of 7.1% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 106
USD 2900.00
(Single User License)
Global Enasidenib Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Enasidenib market size was US$ 88.7 million in 2024 and is forecast to a readjusted size of US$ 142 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 70
USD 4250.00
(Single User License)
Enasidenib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Enasidenib was estimated to be worth US$ 88.7 million in 2024 and is forecast to a readjusted size of US$ 142 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 87
USD 3950.00
(Single User License)
Global Enasidenib Market Research Report 2025
The global market for Enasidenib was valued at US$ 88.7 million in the year 2024 and is projected to reach a revised size of US$ 142 million by 2031, growing at a CAGR of 7.1% during the forecast period.
Published Date: 2025-02-25
Pages: 74
USD 2900.00
(Single User License)
Global Enasidenib Market Insights, Forecast to 2030
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
Published Date: 2024-04-25
Pages: 72
USD 4900.00
(Single User License)
Enasidenib - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
Published Date: 2024-01-24
Pages: 89
USD 3950.00
(Single User License)
Global Enasidenib Market Research Report 2024
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
Published Date: 2024-01-05
Pages: 67
USD 2900.00
(Single User License)

Global Enasidenib Market Research Report 2026
The global Enasidenib market was valued at US$ 94.4 million in 2025 and is anticipated to reach US$ 152 million by 2032, at a CAGR of 7.1% from 2026 to 2032.
Published: 2026-04-27
Pages: 106
USD 2900.00 (Single User License)
Global Enasidenib Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Enasidenib market size was US$ 88.7 million in 2024 and is forecast to a readjusted size of US$ 142 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 70
USD 4250.00 (Single User License)
Enasidenib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Enasidenib was estimated to be worth US$ 88.7 million in 2024 and is forecast to a readjusted size of US$ 142 million by 2031 with a CAGR of 7.1% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 87
USD 3950.00 (Single User License)
Global Enasidenib Market Research Report 2025
The global market for Enasidenib was valued at US$ 88.7 million in the year 2024 and is projected to reach a revised size of US$ 142 million by 2031, growing at a CAGR of 7.1% during the forecast period.
Published: 2025-02-25
Pages: 74
USD 2900.00 (Single User License)
Global Enasidenib Market Insights, Forecast to 2030
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
Published: 2024-04-25
Pages: 72
USD 4900.00 (Single User License)
Enasidenib - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
Published: 2024-01-24
Pages: 89
USD 3950.00 (Single User License)
Global Enasidenib Market Research Report 2024
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
Published: 2024-01-05
Pages: 67
USD 2900.00 (Single User License)